Biotechs investigate mitochondria-targeting drugs to claim a share in the weight loss drug market dominated by GLP-1RAs.

Cosmetic surgeons are seeing a new wave of patients seeking treatment for "Ozempic face" - the sagging, hollow appearance ...

Luka Doncic's drastic body transformation has received a lot of attention, but a recent question by a reporter may have ...

Plastic Surgeon Dr. Bob Basu on if ‘Ozempic face’ is a real concern and why are user seeing side-effects after weight loss.

Yesterday, we reported that Novo Nordisk (NYSE: NVO) stock crashed over 20% in premarket trading yesterday. The main culprit is the reduced sales forecast for the company’s flagship obesity drug ...

We recently published 10 Stocks Hit by Painful Plunge. Novo Nordisk A/S (NYSE:NVO) is one of the best-performing stocks on ...

TAMPA, FL / ACCESS Newswire / July 29, 2025 / The explosive popularity of GLP-1 weight-loss medications such as Ozempic®, ...

The results of the SURPASS-CVOT trial showed that dual GLP-1/GIP agonist Mounjaro (tirzepatide) was as effective as Lilly's ...

GLP-1 medications work by suppressing appetite and altering cravings. That means fewer impulse purchases, smaller baskets and ...

A variety of GLP-1 drugs that were developed to treat Type 2 diabetes, including Novo Nordisk’s Ozempic, have secured label ...

A big wave of criticism and backlash has erupted from the LA Lakers fans after a TV show seemed to question if Dallas ...

What if the key to controlling blood sugar and sugar cravings was already within us? A new study published in Nature ...